Natural Product: NPC471493

Natural Product IDNPC471493
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
CFXLQLVVACEBGI-VHMPTJLLSA-N
IUPAC Name n.a.
Synonyms 7Beta-D-Xylosylbaccatin Iii
Synthetic Gene Cluster n.a.
ChEMBL Identifier CHEMBL252932
PubChem CID 44445497
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000259] Prenol lipids
        • [CHEMONTID:0001551] Diterpenoids
          • [CHEMONTID:0000676] Taxanes and derivatives

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey CFXLQLVVACEBGI-VHMPTJLLSA-N
Standard InCHI InChI=1S/C36H46O15/c1-16-20(39)13-36(45)30(50-31(44)19-10-8-7-9-11-19)28-34(6,29(43)27(48-17(2)37)24(16)33(36,4)5)22(12-23-35(28,15-47-23)51-18(3)38)49-32-26(42)25(41)21(40)14-46-32/h7-11,20-23,25-28,30,32,39-42,45H,12-15H2,1-6H3/t20-,21+,22-,23+,25-,26+,27+,28-,30-,32+,34+,35-,36+/m0/s1
SMILES CC(=O)O[C@@H]1C2=C(C)[C@@H](O)C[C@@](C2(C)C)(O)[C@H]([C@H]2[C@@](C1=O)(C)[C@@H](O[C@H]1OC[C@H]([C@@H]([C@H]1O)O)O)C[C@@H]1[C@]2(CO1)OC(=O)C)OC(=O)c1ccccc1

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   718.28 Volume:   690.635
?
Van der Waals volume.
Dense:   1.04 LogP:   1.033
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.396
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -3.002
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   9.0 Rigid Bonds:   36.0
TPSA:   224.81
?
Topological Polar Surface Area.
H-Bond Acceptor:   15.0
H-Bond Donor:   5.0 Rings:   6.0
Heavy Atoms:   15.0

MedChem Properties

QED Drug-Likeness Score:   0.15 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   6.039 Fsp3:   0.667
MCE-18:   169.2
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   0
Chelating Alert:   0 PAINS Alert:   0
Colloidal aggregators:   0.737 Fluc inhibitor:   0.001
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.013
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.006
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.046 Promiscuous compounds:   0.211

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -5.609 MDCK Permeability:   -4.889
Pgp-inhibitor:   0.022 Pgp-substrate:   1.0
PAMPA:   1.0
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.0
20% Bioavailability (F20%):   0.793 30% Bioavailability (F30%):   0.898
50% Bioavailability (F50%):   0.999

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.979
Plasma Protein Binding (PPB):   70.066% Volume Distribution (VD):   -0.449
Fu: 26.438%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   1.0
OATP1B3 inhibitor:   0.998 BCRP inhibitor:   0.001
BSEP inhibitor:   0.842

ADMET: Metabolism

CYP1A2-inhibitor:   0.0 CYP1A2-substrate:   0.0
CYP2C19-inhibitor:   0.001 CYP2C19-substrate:   0.0
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.0 CYP2D6-substrate:   0.0
CYP3A4-inhibitor:   0.992 CYP3A4-substrate:   0.036
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   0.996
HLM stability:   0.876
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.192 Half-life (T1/2):  3.982

ADMET: Toxicity

hERG Blockers:  0.008 hERG Blockers (10um):  0.205
Human Hepatotoxicity (H-HT):  0.377 Drug-induced Liver Injury (DILI):  0.917
AMES Toxicity:  0.869 Rat Oral Acute Toxicity:  0.367
Maximum Recommended Daily Dose:  0.77 Skin Sensitization:  1.0
Carcinogencity:  0.207 Eye Corrosion:  0.0
Eye Irritation:  0.01 Respiratory Toxicity:  0.073
Drug-induced Neurotoxicity:  0.631 Ototoxicity:  0.845
Hematotoxicity:  0.719 Drug-induced Nephrotoxicity:  0.988
Genotoxicity:  0.999 RPMI-8226 Immunitoxicity:  0.527
A549 Cytotoxicity:  0.514 Hek293 Cytotoxicity:  0.316
BCF:   0.428
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.185
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.939
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   3.954
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO32766 luteibacter sp. Species Rhodanobacteraceae Bacteria n.a. n.a. n.a. PMID[18001087]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT180 Cell line HCT-8 Homo sapiens IC50 < 10000.0 nM DrugMatrix in vitro pharmacology data
NPT181 Cell line Bel-7402 Homo sapiens IC50 < 10000.0 nM DrugMatrix in vitro pharmacology data
NPT547 Cell line BGC-823 Homo sapiens IC50 < 10000.0 nM DrugMatrix in vivo data: Pathology
NPT81 Cell line A549 Homo sapiens IC50 < 10000.0 nM PMID[15165132]
NPT179 Cell line A2780 Homo sapiens IC50 < 10000.0 nM PMID[17346076]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC471493 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6981 Remote Similarity NPC116862
0.6852 Remote Similarity NPC472391
0.6789 Remote Similarity NPC479185
0.6778 Remote Similarity NPC155329
0.6778 Remote Similarity NPC114357
0.6667 Remote Similarity NPC479184
0.663 Remote Similarity NPC259144
0.5914 Remote Similarity NPC38696
0.5841 Remote Similarity NPC289383
0.5826 Remote Similarity NPC479173
0.569 Remote Similarity NPC479186
0.5652 Remote Similarity NPC472392
0.5648 Remote Similarity NPC473490
0.5593 Remote Similarity NPC472375
0.5521 Remote Similarity NPC197037
0.5521 Remote Similarity NPC229545
0.5521 Remote Similarity NPC134685
0.5455 Remote Similarity NPC219419
0.5408 Remote Similarity NPC11588
0.5243 Remote Similarity NPC479175

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471493 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.5315 Remote Similarity NPD8435 Phase 4

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data